MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 530979 | Name: PF-4693627
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

PF-4693627 is a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation.

Chemical Structure

PF-4693627
PF-4693627
CAS#1312815-93-2

Theoretical Analysis

MedKoo Cat#: 530979

Name: PF-4693627

CAS#: 1312815-93-2

Chemical Formula: C26H29Cl2N3O3

Exact Mass: 501.1586

Molecular Weight: 502.44

Elemental Analysis: C, 62.15; H, 5.82; Cl, 14.11; N, 8.36; O, 9.55

Price and Availability

Size Price Availability Quantity
5mg USD 600.00
10mg USD 925.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
PF-4693627; PF 4693627; PF4693627.
IUPAC/Chemical Name
1-[5-chloro-6-(4-chlorophenyl)-2-benzoxazolyl]-N-[(1S,3S)-3-(hydroxymethyl)cyclohexyl]-4-piperidinecarboxamide
InChi Key
CPDNPVKDQXLYHO-JXFKEZNVSA-N
InChi Code
InChI=1S/C26H29Cl2N3O3/c27-19-6-4-17(5-7-19)21-13-24-23(14-22(21)28)30-26(34-24)31-10-8-18(9-11-31)25(33)29-20-3-1-2-16(12-20)15-32/h4-7,13-14,16,18,20,32H,1-3,8-12,15H2,(H,29,33)/t16-,20-/m0/s1
SMILES Code
O=C(C1CCN(C2=NC3=CC(Cl)=C(C4=CC=C(Cl)C=C4)C=C3O2)CC1)N[C@@H]5C[C@@H](CO)CCC5
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Inhibition of mPGES-1, the terminal enzyme in the arachidonic acid/COX pathway to regulate the production of pro-inflammatory prostaglandin PGE2, is considered an attractive new therapeutic target for safe and effective anti-inflammatory drugs

Preparing Stock Solutions

The following data is based on the product molecular weight 502.44 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Arhancet GB, Walker DP, Metz S, Fobian YM, Heasley SE, Carter JS, Springer JR, Jones DE, Hayes MJ, Shaffer AF, Jerome GM, Baratta MT, Zweifel B, Moore WM, Masferrer JL, Vazquez ML. Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation. Bioorg Med Chem Lett. 2013 Feb 15;23(4):1114-9. doi: 10.1016/j.bmcl.2012.11.109. Epub 2012 Dec 6. PubMed PMID: 23260349. Geng, S., Zhan, H., Cao, L., Geng, L., & Ren, X. (2023). Targeting PTGES/PGE2 axis enhances sensitivity of colorectal cancer cells to 5-fluorouracil. Biochemistry and Cell Biology, 101(6), 501-512. Psarra, A., Nikolaou, A., Kokotou, M. G., Limnios, D., & Kokotos, G. (2017). Microsomal prostaglandin E2 synthase-1 inhibitors: a patent review. Expert opinion on therapeutic patents, 27(9), 1047-1059. Kim, M., Kim, G., Kang, M., Ko, D., Nam, Y., Moon, C. S., ... & Lee, J. Y. (2021). Discovery of N-amido-phenylsulfonamide derivatives as novel microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors. Bioorganic & Medicinal Chemistry Letters, 41, 127992.